Le Lézard
Classified in: Health
Subject: HSP

Riverchase Dermatology and Cosmetic Surgery Offers Over 623 Free Skin Cancer Screenings During Skin Cancer Awareness Month in May


FORT MYERS, Fla., April 17, 2019 /PRNewswire/ -- May is Skin Cancer Awareness Month and the American Academy of Dermatology reports that one in five Americans will develop skin cancer by the age of 70. With over 5 million cases diagnosed in the United States each year, skin cancer is the most common form of cancer in the country. Fortunately, skin cancers are easily treated if diagnosed early.

In 2018 Riverchase Dermatology was named top practice and top skin cancer screener in the U.S. by the American Society for Dermatologic Surgery for the fourth consecutive year and is once again opening its doors to new patients of the practice for a complimentary skin cancer screening throughout the month of May. Riverchase is proudly offering 623 screening appointments throughout 24 locations, with 25 providers participating.

"As an organization that is passionate about your skin health, we are committed to building awareness of the dangers of skin cancer and the importance of annual skin cancer screenings. We are excited about the opportunity to give back to our communities and look forward to hosting the most successful screening event in Riverchase history!" says Andrew T. Jaffe, M.D., FAAD, Chief Medical Officer.

Screenings will be available by appointment only during the month of May. With screening events scheduled across 24 Riverchase locations, Riverchase will provide access to members of the communities it serves on the west coast of Florida between Tampa and Marco Island and across the east coast from Boca Raton through Miami.

New patients to the practice may call 1-800-591-3376 or visit riverchasedermatology.com/melanomamay for additional information on dates and locations and to reserve their free skin cancer screening appointment today.

About Riverchase Dermatology and Cosmetic Surgery
Riverchase Dermatology and Cosmetic Surgery is one of Florida's largest and most comprehensive skin centers. Founded in Naples, Florida in 2000 by Andrew T. Jaffe, MD, FAAD, Riverchase has maintained its initial vision of providing the most comprehensive skin cancer, dermatology and cosmetic surgery services for over two decades. The caring and skilled providers at Riverchase use the latest techniques and equipment to diagnose and treat a wide range of skin disorders and cosmetic concerns. Riverchase has many convenient locations throughout Florida. For more information, visit www.RiverchaseDermatology.com.

CONTACT
Maureen Williams
VP of Marketing
mwilliams@riverchasederm.com
239-690-4149

SOURCE Riverchase Dermatology and Cosmetic Surgery


These press releases may also interest you

at 20:09
The report on the global medical sensor market provides qualitative and quantitative analysis for the period from 2017 to 2025.Read the full report: https://www.reportlinker.com/p05765598/?utm_source=PRN The report predicts the global medical sensor...

at 20:09
The report on the global protein assays market provides qualitative and quantitative analysis for the period from 2017 to 2025.Read the full report: https://www.reportlinker.com/p05765595/?utm_source=PRN The report predicts the global protein assays...

at 20:09
Protein Supplements Market Size, Share & Trends Analysis Report By Product (Powder, Ready to Drink), By Application, By Raw Material, By Source, By Distribution Channel, By Region, And Segment Forecasts, 2019 - 2025 Read the full report:...

at 20:09
Global Vessel Sealing Devices Market: OverviewThis report comprises an elaborate executive summary, including a snapshot that provides information about various segments of the global vessel sealing devices market.The report also provides information...

at 20:09
The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018. The healthcare CMO market is estimated to grow with a CAGR of 12.2% from 2019-2027.Read the full report:...

at 20:05
The precision medicine and biotechnology company Macrogen (CEO Kap-Seok Yang, www.macrogen.com/en/) announced on April 24 that it had signed a supply contract with Exosome Plus (CEO Jong-Uk Bu, www.exosomeplus.com) on...



News published on 17 april 2019 at 13:39 and distributed by: